Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$2.67 - $4.68 $27,306 - $47,862
-10,227 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$3.87 - $7.39 $39,578 - $75,577
10,227 New
10,227 $44,000
Q3 2021

Nov 02, 2021

SELL
$4.32 - $6.43 $98,668 - $146,861
-22,840 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$6.33 - $9.91 $31,650 - $49,550
5,000 Added 28.03%
22,840 $145,000
Q1 2021

May 14, 2021

BUY
$6.6 - $9.0 $117,744 - $160,560
17,840 New
17,840 $138,000

Others Institutions Holding CTMX

About CytomX Therapeutics, Inc.


  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $55.4M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.